- CLINICAL PROFESSOR Medicine, Endocrinology, Diabetes and Bone Disease
American Board of Internal Medicine
MD, Jefferson Medical College
Residency, Internal Medicine
University of Michigan Hospitals
Harvard Medical School
Brigham and Women's Hospital
- Dr. Elliot J. Rayfield is a Clinical Professor of Medicine (Endocrinology, Diabetes, and Bone Diseases). He is Board Certified in Internal Medicine and Endocrinology and Metabolism. Dr. Rayfield was President of the American Diabetes Association (New York Downstate Affiliate). He is a Member of the American Society for Clinical Research and a Fellow of the American College of Physicians. He has been active on national committees of the American Diabetes Association, The Endocrine Society, and the American College of Clinical Endocrinology where he serves on the Editorial Board of Endocrine Practice. He focuses on preventative endocrinology
Sidney H. Ingbar Distinguished Service Award
The Jacobi Medallion
Mount Sinai Alumni Association
First Professional Education Service Award
American Diabetes Association, Downstate Affiliate, New York
Fifth Annual Distinguished Research Award, Department of Medicine
Mount Sinai Medical Center
1975 - 1980
NIH Research Career Development Award
National Institutes of Health
1975 - 1976
American Diabetes Association Research and Development Award
Mount Sinai Medical Center
Alpha Omega Alpha
Jefferson Medical College
Galati S, Rayfield E. Approach to the patient with postprandial hypoglycemia. Endocrine Practice 2014; 20: 331-340.
Rayfield E. Clark T Sawin Library and Resource Center: An Update. Endocrine News 2010 September;.
Rayfield E. Evidence-Based Medicine-GAPPNETTM and its Role in Patient Care. Insulin 2010; 5: 74-76.
Magnotti M, Rayfield E. The HumaPenR Luxura TM HD Pen-- What Is the Role of 0.5-Unit Insulin Dosing? . Journal of Diabetes Science and Technology 2010 March; 4.
Rayfield E. Evidence-Based Medicine-A Brief Review. Insulin 2010; 5: 7-10.
Potenza M, Rayfield E. Targeting the Incretin System in Type 2 Diabetes. Mount Sinai Journal of Medicine 2009;.
Farkouh M, Rayfield E, Fuster V. Diabetes and Cardiovascular Disease. In: The Heart (Thirteenth Edition).prettyprintp2028-2058.
LeRoith D, Rayfield E. The benefits of tight glycemic control in type 2 diabetes mellitus. Clinical Cornerstone 2007; 8(Suppl. 7): S19-S29.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Rayfield is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
1150 Park Avenue
New York, NY 10128
- Monday 8:00am - 3:00pm
- Tuesday 10:00am - 3:00pm
- Wednesday 8:00am - 3:00pm
- Thursday 10:00am - 3:00pm
- Friday 8:00am - 3:00pm
- Aetna U.S. Healthcare
- CIGNA - Indemnity
- Empire Blue Cross/Blue Shield
- Medicare Assignment
- Metrahealth/United Health
- Oxford Health Plans
- United Healthcare